SCI Ventures
Investor profile | Builders Republic
About
SCI Ventures is a specialized venture philanthropy fund dedicated to one clear mission: curing spinal cord injury (SCI) and paralysis. Launched in 2024 as a collaborative effort between major foundations (including the Christopher & Dana Reeve Foundation) and leading neuroscientists, the fund bridges the "valley of death" in translational research. SCI Ventures operates as an evergreen model, investing in early-stage therapeutics and technologies with the potential to restore function in humans, while reinvesting 100% of its profits back into further research and future investments.
Key facts
- Type
- Venture Capital
- Stages
- Pre-Seed,Seed,Series A
- Sectors
- Biotech,Life sciences,Healthcare,Diagnostics,Digital health
- Headquarters
- UK
- Offices
- London
- Geographic focus
- France,Europe,USA
- Lead / Follow
- Follower
- Ticket size
- 0.5M€ – 3M€
- Assets under management
- 40M€
- Founded
- 2024
Track record
- Portfolio companies: 8
Notable investments in France
EG 427
Key differentiators
Evergreen,Sector Specialist,Transatlantic footprint